These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10976419)

  • 21. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The hyperstimulation syndrome].
    Kleinstein J
    Gynakologe; 1991 Jun; 24(3):130-5. PubMed ID: 1909990
    [No Abstract]   [Full Text] [Related]  

  • 25. A study to determine whether serum follicle-stimulating hormone can be a marker for ovarian hyperresponse to follicle-maturing drugs for in vitro fertilization.
    Check JH; Pesso R; Peymer M
    Gynecol Obstet Invest; 1997; 43(4):242-4. PubMed ID: 9194622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome.
    Isik AZ; Vicdan K
    Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):208-12. PubMed ID: 11451550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?
    Delvigne A; Carlier C; Rozenberg S
    Fertil Steril; 2001 Oct; 76(4):844-6. PubMed ID: 11591427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.
    Marci R; Senn A; Dessole S; Chanson A; Loumaye E; De Grandi P; Germond M
    Fertil Steril; 2001 Jun; 75(6):1131-5. PubMed ID: 11384638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve.
    Chou LL; Hwu YM; Lin MH; Lin SY; Lee RK
    Taiwan J Obstet Gynecol; 2010 Dec; 49(4):442-8. PubMed ID: 21199746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer.
    Sher G; Salem R; Feinman M; Dodge S; Zouves C; Knutzen V
    Obstet Gynecol; 1993 Jun; 81(6):1009-11. PubMed ID: 8497341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The syndrome of ovarian hyperstimulation].
    Germond M; Gaillard MC; Senn A
    Arch Gynecol Obstet; 1989; 246 Suppl():S53-64. PubMed ID: 2511811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation.
    Abdalla H; Nicopoullos JD
    Fertil Steril; 2010 Oct; 94(5):1757-63. PubMed ID: 19939366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian hyper-response to administration of an GnRH-agonist without gonadotropins.
    Park HT; Bae HS; Kim T; Kim SH
    J Korean Med Sci; 2011 Oct; 26(10):1394-6. PubMed ID: 22022197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent ovarian hyperstimulation syndrome with perforated appendicitis following induction ovulation with HMG and HCG.
    Bouzari Z; Yazdani S; Sadeghi T
    Am J Emerg Med; 2016 Oct; 34(10):2051.e5-2051.e6. PubMed ID: 27066875
    [No Abstract]   [Full Text] [Related]  

  • 37. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
    Lindheim SR; Cohen MA; Chang PL; Sauer MV
    J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome.
    Ohata Y; Harada T; Ito M; Yoshida S; Iwabe T; Terakawa N
    Gynecol Obstet Invest; 2000; 50(3):186-8. PubMed ID: 11014952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.